source
- For wearables, it’s a GLP-1 worldWe have two pieces of wearables-related news for you today, and (maybe unsurprisingly) GLP-1s came up in our conversations with both companies. First, Signos raised $20 million for its approach ...Endpoints · 2mo ago↗ source
- CVS obesity drug deal puts Lilly on equal footing with NovoThe agreement includes Lilly’s new pill Foundayo and restores coverage for Zepbound, erasing what had been a commercial edge for rival Novo Nordisk.BioPharma Dive · 2mo ago↗ source
- ICON audit finds overstated revenue; Secretome and Psilera raise cash👀 ICON’s audit probe is complete: The investigation found that ICON’s revenue was overstated by $65.3 million in 2023 (about 0.8% of its total revenue that year) and by $92.7 million in 2024 (1.1%…Endpoints